CSTB and Myoclonus: Observational evidence suggests that compared to those with biallelic repeat expansions, the minority of patients who have EPM1 due to compound heterozygous mutations may have a more severe phenotype, as evidenced by earlier age at onset and the severity of myoclonus.1